Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Emotional difficulties were consistently elevated among children and young people from low income households over a month of lockdown compared to those from higher income households.

Young child looking out of a window

The most recent report from the Co-SPACE (COVID-19 Supporting Parents, Adolescents, and Children in Epidemics) study highlights that:

  • Emotional and restless/attention difficulties (and behaviour difficulties for primary school aged children) were consistently elevated among children and young people from low income households over a month of lockdown compared to those from higher income households, with around two and a half times as many children experiencing significant problems in low income households.
  • Parents and carers from low income households reported that their children (aged 4 to 16 years) had higher levels of emotional difficulties, such as feeling unhappy, worried, being clingy and experiencing physical symptoms associated with worry than those from higher income households. Their children were also more fidgety and restless and had greater difficulty paying attention. Those with younger, primary school aged children also reported that their children were experiencing higher levels of behaviour difficulties, including temper tantrums, arguments and not doing what they were being asked to do by adults than those from higher incomes.

Read more about the report findings on the Department of Experimental Psychology website

The story is also available on the University of Oxford website

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.